Clinafloxacin is a fluoroquinolone antibacterial currently under research. It has been proven to present good antibiotic properties. However, its approval and release have been halted due to the presence of serious side effects.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cilostazol | The serum concentration of Cilostazol can be increased when it is combined with Clinafloxacin. |
| Zolmitriptan | The metabolism of Zolmitriptan can be decreased when combined with Clinafloxacin. |
| Picosulfuric acid | The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Clinafloxacin. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin pork. |
| Metformin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Metformin. |
| Bromocriptine | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Bromocriptine. |
| Mitiglinide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Mitiglinide. |
| Glymidine | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glymidine. |
| AICA ribonucleotide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with AICA ribonucleotide. |
| Buformin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Buformin. |
| Vildagliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Vildagliptin. |
| Voglibose | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Voglibose. |
| NN344 | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with NN344. |
| AMG-222 | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with AMG-222. |
| Bisegliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Bisegliptin. |
| Gosogliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Gosogliptin. |
| Linagliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Linagliptin. |
| Canagliflozin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Canagliflozin. |
| Benfluorex | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Benfluorex. |
| Empagliflozin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Empagliflozin. |
| Albiglutide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Albiglutide. |
| Dulaglutide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Dulaglutide. |
| Lobeglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Lobeglitazone. |
| Netoglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Netoglitazone. |
| Rivoglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Rivoglitazone. |
| Ciglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Ciglitazone. |
| Lixisenatide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Lixisenatide. |
| Insulin degludec | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin degludec. |
| Insulin peglispro | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin peglispro. |
| Insulin tregopil | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin tregopil. |
| Ipragliflozin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Ipragliflozin. |
| Dutogliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Dutogliptin. |
| Allicin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Allicin. |
| Tofogliflozin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Tofogliflozin. |
| Ertugliflozin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Ertugliflozin. |
| 2,4-thiazolidinedione | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with 2,4-thiazolidinedione. |
| Teneligliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Teneligliptin. |
| Omarigliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Omarigliptin. |
| Carmegliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Carmegliptin. |
| Gemigliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Gemigliptin. |
| Anagliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Anagliptin. |
| Evogliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Evogliptin. |
| Sotagliflozin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Sotagliflozin. |
| Balaglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Balaglitazone. |
| Remogliflozin etabonate | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Remogliflozin etabonate. |
| Guar gum | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Guar gum. |
| Semaglutide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Semaglutide. |
| Taspoglutide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Taspoglutide. |
| Englitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Englitazone. |
| Tirzepatide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Tirzepatide. |
| Gastric inhibitory polypeptide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Gastric inhibitory polypeptide. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin glargine. |
| Sulfisoxazole | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Sulfisoxazole. |
| Acarbose | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Acarbose. |
| Sulfadiazine | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Sulfadiazine. |
| Miglitol | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Miglitol. |
| Mifepristone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Mifepristone. |
| Repaglinide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Repaglinide. |
| Sitagliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Sitagliptin. |
| Sunitinib | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Sunitinib. |
| Exenatide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Exenatide. |
| Mecasermin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Mecasermin. |
| Pramlintide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Pramlintide. |
| Insulin aspart | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin aspart. |
| Insulin detemir | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin detemir. |
| Insulin glulisine | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin glulisine. |
| Saxagliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Saxagliptin. |
| Liraglutide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Liraglutide. |
| Troglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Troglitazone. |
| Glimepiride | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glimepiride. |
| Rosiglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Rosiglitazone. |
| Acetohexamide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Acetohexamide. |
| Chlorpropamide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Chlorpropamide. |
| Nateglinide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Nateglinide. |
| Tolazamide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Tolazamide. |
| Sulfamethoxazole | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Sulfamethoxazole. |
| Glyburide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glyburide. |
| Glipizide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glipizide. |
| Gliclazide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Gliclazide. |
| Tolbutamide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Tolbutamide. |
| Pioglitazone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Pioglitazone. |
| Gliquidone | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Gliquidone. |
| Glisoxepide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glisoxepide. |
| Glibornuride | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glibornuride. |
| Carbutamide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Carbutamide. |
| Metahexamide | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Metahexamide. |
| Pentamidine | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Pentamidine. |
| Phenformin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Phenformin. |
| Alogliptin | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Alogliptin. |
| Insulin beef | The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Insulin beef. |
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Clinafloxacin. |
| Octreotide | The risk or severity of hypoglycemia can be increased when Octreotide is combined with Clinafloxacin. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Clinafloxacin. |
| Pregabalin | The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Clinafloxacin. |
| Gatifloxacin | The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Clinafloxacin. |
| Zimelidine | The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Clinafloxacin. |
| Milnacipran | The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Clinafloxacin. |
| Pasireotide | The risk or severity of hypoglycemia can be increased when Pasireotide is combined with Clinafloxacin. |